• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Cleveland BioLabs, Inc. (CBLI)

    -NasdaqCM
    2.93 Up 0.11(3.90%) Jun 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:2.82
    Open:3.13
    Bid:2.82 x 100
    Ask:3.54 x 100
    1y Target Est:2.00
    Beta:2.89
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:2.73 - 3.20
    52wk Range:1.84 - 13.80
    Volume:215,606
    Avg Vol (3m):221,894
    Market Cap:11.73M
    P/E (ttm):N/A
    EPS (ttm):-0.16
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CBLI

    Comparison

    Symbol% ChgMkt Cap
    CBLIUp 3.90%11.73M
    AMGNDown 0.38%118.95B
    AZNDown 0.06%84.69B
    OSIRUp 0.81%641.72M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate is Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is developing as a... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback